Amneal Pharmaceuticals Recalls Chlorpromazine Hydrochloride Tablets
Amneal Pharmaceuticals recalled 3,363 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. The recall stems from the presence of a microorganism in packaging material. No microorganisms were detected in the tablets themselves, but consumers should stop using the product immediately.
Product Details
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 200 mg, in 100-count bottles. The lot numbers affected are AM240336 and AM240337, with an expiration date of February 28, 2027. The product was distributed nationwide.
The Hazard
The recall is due to the presence of a foreign substance detected in auxiliary polyester coil used in packaging. Although no microorganisms were found in the tablets, the risk of contamination remains.
Reported Incidents
No incidents or injuries have been reported related to the contaminated packaging. The recall was initiated proactively to ensure consumer safety.
What to Do
Stop using the recalled product immediately. Contact Amneal Pharmaceuticals, LLC or consult your healthcare provider for further guidance.
Contact Information
For more information, visit the FDA website or contact Amneal Pharmaceuticals at their customer service number.